Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Michael J. Barry, Wanda K. Nicholson, Michael Silverstein, Michael D. Cabana, David Chelmow, Tumaini Rucker Coker, Esa M. Davis, Katrina E. Donahue, Carlos Roberto Jaén, Li Li, Gbenga Ogedegbe, Goutham Rao, John M. Ruiz, James Stevermer, Joel Tsevat, Sandra Millon Underwood, John B. Wong

Research output: Contribution to journalReview articlepeer-review

Abstract

Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10000 deliveries in 1993 to 1021 cases per 10000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

Original languageEnglish (US)
Pages (from-to)1074-1082
Number of pages9
JournalJAMA
Volume330
Issue number11
DOIs
StatePublished - Sep 19 2023

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement'. Together they form a unique fingerprint.

Cite this